28/04/2026
We are excited to witness the launch of the WHO Global Hepatitis Report 2026 here at the World Hepatitis Summit.
This report provides a consolidated global estimates on viral hepatitis, highlighting both the progress made and the urgent gaps that remain as we strive for 2030 elimination goals.
The data is a sobering reminder of why our work at Sediba Hope Medical Centre is so vital:
* An estimated 14 million people worldwide inject drugs—approximately 0.3% of the global population aged 15–64.
* While only 0.6% of the general population lives with HCV, an estimated 39% of people who inject drugs are living with the infection.
* The risk of HCV infection through shared needles is 5–10 times higher than the risk for HIV.
* Globally, only 18 per 100 people who inject drugs access to opioid agonist maintenance therapy.
At Sediba Hope Medical Centre, we are committed to turning these global insights into local action through our integrated approach for those most affected.
Read the full report here:
https://iris.who.int/items/b89fc26c-9fdb-465a-ae3d-a325a35bd4e7